Epitopkartierung von FIX-neutralisierenden Antikörpern in Hämophilie-B-Patienten

• Literatur

• 1 Lollar P. Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX. J Thromb Haemost 2004; 2: 1082-1095.
• 2 Christophe OD, Lenting PJ, Cherel G. et al. Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B. Blood 2001; 98: 1416-1423.
• 3 Vysotchin A, Medved LV, Ingham KC. Domain structure and domain-domain interactions in human coagulation factor IX. J Biol Chem 1993; 268: 8436-8446.
• 4 DiMichele D. Inhibitor development in haemophilia B: an orphan disease in need of attention. Br J Haematol 2007; 138: 305-315.
• 5 Chang YJ, Wu HL, Hsu YC. et al. Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5. Thromb Res 2003; 111: 293-299.
• 6 Takahashi I, Kojima T, Sano M. et al. Detailed characterization of an anti-factor IX monoclonal antibody that neutralizes the prolonged ox brain prothrombin time of hemophilia B(M) by synthetic peptides. Peptides 2000; 21: 603-608.
• 7 Königs C, Rowley MJ, Thompson P. et al. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120. Eur J Immunol 2000; 30: 1162-1171.
• 8 Brandstetter H, Bauer M, Huber R. et al. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci USA 1995; 92: 9796-9800.
• 9 Schreiber A, Humbert M, Benz A. et al. 3D-Epitope-Explorer: localization of conformational epitopes within three-dimensional structures of proteins. J Comput Chem 2005; 26: 879-887.
• 10 Kulkarni-Kale U, Bhosle S, Kolaskar AS. CEP: a conformational epitope prediction server. Nucl Acid Res 2005; 33: W168-W171.
• 11 Kolkman JA, Lenting PJ, Mertens K. Regions 301–303 and 333–339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity. Biochem J 1999; 339: 217-221.